Genelux (GNLX) Shares Issued (2022 - 2026)

Genelux (GNLX) posted quarterly Shares Issued of $4.3 million for Q1 2026, down 35.38% quarter-over-quarter from $6.7 million in Q4 2025.

Genelux (GNLX) Shares Issued (2022 - 2026) Analysis & Trends

Genelux's Shares Issued history runs 5 years deep, the most recent figure standing at $4.3 million for Q1 2026.

In Q1 2026, Shares Issued changed N/A year-over-year to $4.3 million; the TTM figure through Mar 2026 stood at $4.3 million (changed N/A YoY), while the FY2025 annual figure was $6.7 million, up 24.87% from the prior year.
Shares Issued for Q1 2026 stood at $4.3 million, down from $6.7 million in the prior quarter.
The five-year high for Shares Issued was $6.7 million in Q4 2025, with the low at $2.8 million in Q3 2022.
The 5-year median for Shares Issued is $4.2 million (2025), against an average of $4.5 million.
The sharpest annual moves came in 2023 and 2024: Shares Issued surged 82.29% in 2023, then decreased 25.93% in 2024.
Genelux's Shares Issued stood at $4.2 million in 2022, then gained by 21.85% to $5.1 million in 2023, then advanced by 5.01% to $5.4 million in 2024, then climbed by 24.87% to $6.7 million in 2025, then tumbled by 35.38% to $4.3 million in 2026.
Business Quant data shows GNLX's Shares Issued at $4.3 million in Q1 2026, $6.7 million in Q4 2025, and $4.2 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Issued (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Genelux	119.87 Mn	119.87 Mn	-	6.92 Mn

Download Data